Certified by Founder Lodge
Tessera Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $300,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our mission is to cure disease by writing the code of life
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 19 ,2022 | Series C | $300,000,000 |
Hanwha Impact Partners
March Capital
T. Rowe Price
Alaska Permanent Fund Corporation
ARTIS Ventures
Flagship Pioneering
Longevity Vision Fund
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
